Sequence variant on 8q24 confers susceptibility to urinary bladder cancer

Nature Genetics

Volumn 40, Issue 11, 2008, Pages 1307-1312

  Kiemeney, Lambertus A ^a,b   Thorlacius, Steinunn ^c   Sulem, Patrick ^c   Geller, Frank ^c   Aben, Katja K H ^a,b   Stacey, Simon N ^c   Gudmundsson, Julius ^c   Jakobsdottir, Margret ^c   Bergthorsson, Jon T ^c   Sigurdsson, Asgeir ^c   Blondal, Thorarinn ^c   Witjes, J Alfred ^a   Vermeulen, Sita H ^a   Hulsbergen Van De Kaa, Christina A ^a   Swinkels, Dorine W ^a   Ploeg, Martine ^a   Cornel, Erik B ^d   Vergunst, Henk ^e   Thorgeirsson, Thorgeir E ^c   Gudbjartsson, Daniel ^c   Gudjonsson, Sigurjon A ^c   Thorleifsson, Gudmar ^c   Kristinsson, Kari T ^c   Mouy, Magali ^c   Snorradottir, Steinunn ^c   Placidi, Donatella ^f   Campagna, Marcello ^f   Arici, Cecilia ^f   Koppova, Kvetoslava ^g   Gurzau, Eugene ^h   Rudnai, Peter ⁱ   Kellen, Eliane ^j   Polidoro, Silvia ^k,l   Guarrera, Simonetta ^k,l   Sacerdote, Carlotta ^l   Sanchez, Manuel ^m   Saez, Berta ⁿ   Valdivia, Gabriel ^o   Ryk, Charlotta ^p   De Verdier, Petra ^p   Lindblom, Annika ^p   Golka, Klaus ^q   Bishop, D Timothy ^r   Knowles, Margaret A ^r   Nikulasson, Sigfus ^s   Petursdottir, Vigdis ^s   Jonsson, Eirikur ^s   Geirsson, Gudmundur ^s   Kristjansson, Baldvin ^s   Mayordomo, Jose I ^m,n   Steineck, Gunnar ^t,u   Porru, Stefano ^f   Buntinx, Frank ^j,v   Zeegers, Maurice P ^w,x   Fletcher, Tony ^y   Kumar, Rajiv ^z   Matullo, Giuseppe ^k,l   Vineis, Paolo ^k,aa   Kiltie, Anne E ^r   Gulcher, Jeffrey R ^c   Thorsteinsdottir, Unnur ^c,ab   Kong, Augustine ^c   Rafnar, Thorunn ^c   Stefansson, Kari ^c,ab   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Integraal Kankercentrum Oost   (Netherlands)

^c DECODE GENETICS   (Iceland)

^d Streekziekenhuis Midden Twente ^*  (Netherlands)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^f UNIVERSITY OF BRESCIA   (Italy)

^g State Health Institute   (Slovakia)

^h Environmental Health Center   (Romania)

ⁱ NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^j UNIVERSITY OF LEUVEN   (Belgium)

^k ISI FOUNDATION   (Italy)

^l UNIVERSITY OF TURIN   (Italy)

^m HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

ⁿ Health Science Institute   (Spain)

^o UNIVERSITY OF ZARAGOZA   (Spain)

^p KAROLINSKA INSTITUTE   (Sweden)

^q LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^r ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^s LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^t KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^u SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^v MAASTRICHT UNIVERSITY   (Netherlands)

^w UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^x MAASTRICHT UNIVERSITY   (Netherlands)

^y LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^z GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^aa IMPERIAL COLLEGE LONDON   (United Kingdom)

^ab UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN P63;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 3Q; CHROMOSOME 8Q; CHROMOSOME VARIANT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 55049112064     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.229     Document Type: Article

References (30)

1. Division of Cancer Control and Population Sciences, National Cancer Institute. Surveillance, Epidemiology, and End Results Program 1975-2004. ohttp://seer.cancer.gov/csr/1975_2004/results_merged/ sect_27_urinary_bladder. pdf4 (2007).
2. Aben, K.K. et al. Familial aggregation of urothelial cell carcinoma. Int. J. Cancer 98, 274-278 (2002).
3. Amundadottir, L.T. et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med. 1, e65 (2004).
4. Murta-Nascimento, C. et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol. Biomarkers Prev. 16, 1595-1600 (2007).
5. Aben, K.K. et al. Segregation analysis of urothelial cell carcinoma. Eur. J. Cancer 42, 1428-1433 (2006).
6. Gudmundsson, J. et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat. Genet. 39, 631-637 (2007).
7. Gudmundsson, J. et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 39, 977-983 (2007).
8. Stacey, S.N. et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat. Genet. 39, 865-869 (2007).
9. Easton, D.F. et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093 (2007).
10. Tomlinson, I. et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat. Genet. 39, 984-988 (2007).
11. DePinho, R.A., Schreiber-Agus, N. & Alt, F.W. Myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res. 57, 1-46 (1991).
12. Mhawech-Fauceglia, P., Cheney, R.T. & Schwaller, J. Genetic alterations in urothelial bladder carcinoma: an updated review. Cancer 106, 1205-1216 (2006).
13. Gombert, W.M. et al. The c-myc insulator element and matrix attachment regions define the c-myc chromosomal domain. Mol. Cell. Biol. 23, 9338-9348 (2003).
14. Hallikas, O. et al. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124, 47-59 (2006).
15. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423-428 (2008).
16. Urist, M.J. et al. Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol. 161, 1199-1206 (2002).
17. Koga, F. et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res. 9, 5501-5507 (2003).
18. Amundadottir, L.T. et al. A common variant associated with prostate cancer in European and African populations. Nat. Genet. 38, 652-658 (2006).
19. Yeager, M. et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39, 645-649 (2007).
20. Saccone, S.F. et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 16, 36-49 (2007).
21. Thorgeirsson, T.E. et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452, 638-642 (2008).
22. Amos, C.I. et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616-622 (2008).
23. Hung, R.J. et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452, 633-637 (2008).
24. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131-138 (2003).
25. Falk, C.T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227-233 s(1987).
26. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719-748 (1959).
27. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997-1004 (1999).
28. Schadt, E.E. et al. Genetics of gene expression surveyed in maize, mouse and man. Nature 422, 297-302 (2003).
29. Stefansson, H. et al. A common inversion under selection in Europeans. Nat. Genet. 37, 129-137 (2005).
30. Epstein, J.I., Amin, M.B., Reuter, V.R. & Mostofi, F.K. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 22, 1435-1448 (1998).